Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Jianjie Ma to Join The Ohio State University Team 



We are delighted to announce the appointment of Jianjie Ma, PhD, as Professor in the Department of Surgery, the Karl P. Klassen Chair of Thoracic Surgery in the Department of Surgery, effective July 1, 2012, pending the approval of The Ohio State University Board of Trustees. He will also be engaged as a Davis Heart Lung Research Institute Investigator and serve on the advisory committee of the newly formed Center for Regenerative Medicine and Cell-Based Therapies in the College of Medicine.

Dr. Ma comes to Ohio State from the Robert Wood Johnson Medical School at the University of Medicine and Dentistry of New Jersey (UMDNJ) where he is a university-named professor and acting chair of the Department of Physiology and Biophysics, as well as Chief of the Division of Developmental Medicine and Research. During his time at UMDNJ, Dr. Ma founded the Graduate Program in Physiology and Integrative Biology, which is jointly sponsored by UMDNJ and Rutgers University. He served on the Scientific Advisory Board for the Cancer Institute of New Jersey. In addition, he served on several National Institutes of Health study sections and various editorial boards.

In addition to his faculty appointment with UMDNJ, Dr. Ma also founded his own company, TRIM-edicine Inc., a university spinoff biotechnology company. TRIM-edicine develops novel biopharmaceutical products for the treatment of several important unmet medical needs. One specific therapeutic protein is MG53, which targets diseases involved chronic and acute tissue damage. The other drug is ATAP, which targets apoptosis for cancer treatment.

Dr. Ma is an NIH-funded researcher, prominently and widely published on the topics of muscle physiology, aging, cardiovascular disease, cystic fibrosis, apoptosis and cancer biology. He has authored more than 130 publications and holds 10 patents. He has assembled an international team of collaborators working on translational research. His group maintains close collaboration with pharmaceutical industries for joint development efforts toward translating basic discovery into clinical application.

Dr. Ma received his bachelor’s degree in Physics from Wuhan University in China, and came to the United States through the CUSPEA (China-US Physics Examination Application) program after his undergraduate education. He was chosen to represent the Department of Physiology and Biophysics at the Graduate Student Symposium of Baylor College of Medicine, where he received his PhD in 1989. Dr. Ma went on to become an Instructor of Physiology at Rush Medical College (1989-1991) where he received postdoctoral fellowship and research grants from the Muscular Dystrophy Association, and a University Committee on Research Grant Award. Dr. Ma joined the Department of Physiology and Biophysics at Case Western Reserve University in 1992, and became a tenured Associate Professor in 1997. In 2001, he was recruited to UMDNJ as a university-named professor.

Dr. Ma has trained numerous graduate and postgraduate students, and many of them have become leaders in academia, industry, medicine and law firms. He was an established investigator for the American Heart Association (AHA) and served as advisor for many AHA postdoctoral and scientist development fellows. He is an outstanding mentor and educator, and has coordinated the teaching of both medical and graduate students at Case Western Reserve University as well as the Robert Wood Johnson Medical School. He is also actively involved in teaching and collaboration with the Chinese Academy of Sciences and universities in China.

Please join us in welcoming Dr. Ma to the Department of Surgery and Dorothy M. Davis Heart and Lung Research Institute.



Posted on 29-May-12 by Toto, Brent
Tags: OSU Regenerative Medicine News, Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: